Efficacy of bevacizumab in the treatment of refractory brain edema of metastatic tumors from different sources
Author:
Affiliation:
1. The First Affiliated Hospital, Jinan University, Guangzhou, China
2. Peking University Health Science Center, Peking University, Beijing, China
Publisher
Informa UK Limited
Link
https://www.tandfonline.com/doi/pdf/10.1080/01616412.2021.1948740
Reference23 articles.
1. Brain metastases
2. Levels of vascular endothelial growth factor, hepatocyte growth factor/scatter factor and basic fibroblast growth factor in human gliomas and their relation to angiogenesis
3. Vascular endothelial growth factor expression correlates with tumour grade and vascularity in gliomas
4. Bevacizumab for malignant gliomas: current indications, mechanisms of action and resistance, and markers of response
5. Production of vascular endothelial growth factor by human tumors inhibits the functional maturation of dendritic cells
Cited by 10 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Health-Related Quality of Life in Neuro-Oncology;Reference Module in Neuroscience and Biobehavioral Psychology;2025
2. A Phase II Trial of Bevacizumab in Patients with Recurrent/Progressive Solid Tumor Brain Metastases That Have Progressed Following Whole-Brain Radiation Therapy;Cancers;2024-06-04
3. Efficiency of radiotherapy plus Anlotinib in alleviating edema and increasing radiosensitivity in symptomatic brain metastasis patients: A retrospective study;2024-04-05
4. Effect of Bevacizumab on traumatic penumbra brain edema in rats at different time points;Tissue Barriers;2023-12-12
5. Lenvatinib or anti-VEGF in combination with anti–PD-1 differentially augments antitumor activity in melanoma;JCI Insight;2023-04-10
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.7亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2025 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3